{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:34:03Z","timestamp":1777624443882,"version":"3.51.4"},"reference-count":85,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cirrhotic cardiomyopathy (CCM) is defined as cardiac dysfunction associated with cirrhosis in the absence of pre-existing heart disease. CCM manifests as the enlargement of cardiac chambers, attenuated systolic and diastolic contractile responses to stress stimuli, and repolarization changes. CCM significantly contributes to mortality and morbidity in patients who undergo liver transplantation and contributes to the pathogenesis of hepatorenal syndrome\/acute kidney injury. There is currently no specific treatment. The traditional management for non-cirrhotic cardiomyopathies, such as vasodilators or diuretics, is not applicable because an important feature of cirrhosis is decreased systemic vascular resistance; therefore, vasodilators further worsen the peripheral vasodilatation and hypotension. Long-term diuretic use may cause electrolyte imbalances and potentially renal injury. The heart of the cirrhotic patient is insensitive to cardiac glycosides. Therefore, these types of medications are not useful in patients with CCM. Exploring the therapeutic strategies of CCM is of the utmost importance. The present review summarizes the possible treatment of CCM. We detail the current status of non-selective beta-blockers (NSBBs) in the management of cirrhotic patients and discuss the controversies surrounding NSBBs in clinical practice. Other possible therapeutic agents include drugs with antioxidant, anti-inflammatory, and anti-apoptotic functions; such effects may have potential clinical application. These drugs currently are mainly based on animal studies and include statins, taurine, spermidine, galectin inhibitors, albumin, and direct antioxidants. We conclude with speculations on the future research directions in CCM treatment.<\/jats:p>","DOI":"10.3390\/ijms25115849","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T03:48:49Z","timestamp":1716868129000},"page":"5849","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-5177","authenticated-orcid":false,"given":"Hongqun","family":"Liu","sequence":"first","affiliation":[{"name":"Liver Unit, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6670-4420","authenticated-orcid":false,"given":"Daegon","family":"Ryu","sequence":"additional","affiliation":[{"name":"Liver Unit, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada"},{"name":"Division of Gastroenterology, Yangsan Hospital, Pusan National University School of Medicine, Pusan 46033, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-9379","authenticated-orcid":false,"given":"Sangyoun","family":"Hwang","sequence":"additional","affiliation":[{"name":"Liver Unit, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada"},{"name":"Department of Internal Medicine, Dongnam Institute of Radiological and Medical Sciences, Pusan 46033, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-272X","authenticated-orcid":false,"given":"Samuel S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Liver Unit, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"ref_1","first-page":"530","article-title":"Cardiac abnormalities in liver cirrhosis","volume":"151","author":"Lee","year":"1989","journal-title":"West J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"849253","DOI":"10.3389\/fnetp.2022.849253","article-title":"Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy","volume":"2","author":"Liu","year":"2022","journal-title":"Front. Netw. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100911","DOI":"10.1016\/j.jhepr.2023.100911","article-title":"Cardiomyopathy in cirrhosis: From pathophysiology to clinical care","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/hep.32021","article-title":"Diagnostic Criteria of Cirrhotic Cardiomyopathy: Out with the Old, in With the New?","volume":"74","author":"Liu","year":"2021","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11894-020-00783-1","article-title":"Cirrhotic Cardiomyopathy","volume":"22","author":"Yoon","year":"2020","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/lt.24768","article-title":"Cirrhotic cardiomyopathy: Implications for liver transplantation","volume":"23","author":"Liu","year":"2017","journal-title":"Liver. Transpl"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jceh.2018.08.008","article-title":"Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis","volume":"9","author":"Premkumar","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840120306","article-title":"Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats","volume":"12","author":"Lee","year":"1990","journal-title":"Hepatology"},{"key":"ref_9","first-page":"G87","article-title":"Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats","volume":"267","author":"Ma","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1111\/liv.14599","article-title":"Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy","volume":"40","author":"Honar","year":"2020","journal-title":"Liver Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12072-014-9531-y","article-title":"Cirrhotic cardiomyopathy: Review of pathophysiology and treatment","volume":"8","author":"Chayanupatkul","year":"2014","journal-title":"Hepatol. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cnc.2022.04.005","article-title":"Management of the Adult Patient with Cirrhosis Complicated by Ascites","volume":"34","author":"Nobbe","year":"2022","journal-title":"Crit. Care Nurs. Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","article-title":"Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group","volume":"324","author":"Poynard","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MEG.0000000000001128","article-title":"Beta-Blocker therapy for cirrhotic cardiomyopathy: A randomized-controlled trial","volume":"30","author":"Silvestre","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MCG.0000000000001219","article-title":"Carvedilol Combined with Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis","volume":"54","author":"Premkumar","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2007.11.012","article-title":"Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis","volume":"48","author":"Zambruni","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2003.10.026","article-title":"Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis","volume":"40","author":"Henriksen","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(80)90063-X","article-title":"Propranolol\u2014A medical treatment for portal hypertension?","volume":"2","author":"Lebrec","year":"1980","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.1840020503","article-title":"Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis","volume":"2","author":"Hillon","year":"1982","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"Baveno","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: Haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/ijmy.ijmy_243_21","article-title":"Clinical profile, diagnosis, treatment, and outcome of patients with tubercular versus nontubercular causes of spine involvement: A retrospective cohort study from India","volume":"11","author":"Gupta","year":"2022","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jhep.2020.05.011","article-title":"Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites","volume":"73","author":"Tellez","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0168-8278(98)80022-6","article-title":"The sympathetic nervous system in liver disease","volume":"29","author":"Henriksen","year":"1998","journal-title":"J. Hepatol."},{"key":"ref_28","first-page":"R390","article-title":"Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity","volume":"238","author":"Kostreva","year":"1980","journal-title":"Am. J. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"803984","DOI":"10.3389\/fcvm.2021.803984","article-title":"Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases","volume":"8","author":"Li","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41401-021-00734-0","article-title":"Glibenclamide alleviates beta adrenergic receptor activation-induced cardiac inflammation","volume":"43","author":"Cao","year":"2022","journal-title":"Acta. Pharmacol. Sin."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrcardio.2016.185","article-title":"Inflammatory processes in cardiovascular disease: A route to targeted therapies","volume":"14","author":"Ruparelia","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3350\/cmh.2012.18.4.337","article-title":"The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension","volume":"18","author":"Seo","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12325-013-0044-1","article-title":"Targeting the gut-liver axis in cirrhosis: Antibiotics and non-selective beta-blockers","volume":"30","author":"Madsen","year":"2013","journal-title":"Adv. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2016.11.001","article-title":"Beta adrenergic blockade and decompensated cirrhosis","volume":"66","author":"Reiberger","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.0742-2822.2004.03102.x","article-title":"Metoprolol CR\/XL improves systolic and diastolic left ventricular function in patients with chronic heart failure","volume":"21","author":"Hole","year":"2004","journal-title":"Echocardiography"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2020.03.048","article-title":"Short-term hemodynamic effects of beta-blockers influence survival of patients with decompensated cirrhosis","volume":"73","author":"Ardevol","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3350\/cmh.2020.0234","article-title":"beta-blockers in advanced cirrhosis: More friend than enemy","volume":"27","author":"Yoon","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.5009\/gnl210537","article-title":"Prolonged QT Interval in Cirrhosis: Twisting Time?","volume":"16","author":"Lee","year":"2022","journal-title":"Gut. Liver"},{"key":"ref_39","first-page":"224","article-title":"Propranolol reduces systemic oxidative stress and endotoxemia in cirrhotic patients with esophageal varices","volume":"31","author":"Taprantzi","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Liu, H., Nguyen, H.H., Hwang, S.Y., and Lee, S.S. (2023). Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316805"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","article-title":"Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: Interaction between TNFalpha and endocannabinoids","volume":"53","author":"Yang","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/CS20130642","article-title":"Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice","volume":"127","author":"Nam","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.dld.2012.06.020","article-title":"Protective effects of erythropoietin on cirrhotic cardiomyopathy in rats","volume":"44","author":"Liu","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: Molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients with Decompensated Cirrhosis","volume":"157","author":"Fernandez","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5114\/ceh.2020.99513","article-title":"Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms","volume":"6","author":"Mousavi","year":"2020","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FJC.0000000000000872","article-title":"Protective Effects of Spermidine Against Cirrhotic Cardiomyopathy in Bile Duct-Ligated Rats","volume":"76","author":"Sheibani","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3350\/cmh.2021.0141","article-title":"Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats","volume":"28","author":"Yoon","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"120966","DOI":"10.1016\/j.lfs.2022.120966","article-title":"Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats","volume":"308","author":"Niaz","year":"2022","journal-title":"Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","article-title":"Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy","volume":"108","author":"Node","year":"2003","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1476-511X-12-47","article-title":"The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy\u20145-year follow-up","volume":"12","author":"Mikhailidis","year":"2013","journal-title":"Lipids Health Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/108155890405200433","article-title":"Statin therapy for cardiac hypertrophy and heart failure","volume":"52","author":"Liao","year":"2004","journal-title":"J. Investig. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Tang, H.Y., Huang, J.E., Tsau, M.T., Chang, C.J., Tung, Y.C., Lin, G., and Cheng, M.L. (2023). Metabolomics Assessment of Volume Overload-Induced Heart Failure and Oxidative Stress in the Kidney. Metabolites, 13.","DOI":"10.3390\/metabo13111165"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3892\/mmr.2021.12242","article-title":"Protective role of taurine against oxidative stress (Review)","volume":"24","author":"Baliou","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Schaffer, S.W., Jong, C.J., Ramila, K.C., and Azuma, J. (2010). Physiological roles of taurine in heart and muscle. J. Biomed. Sci., 17.","DOI":"10.1186\/1423-0127-17-S1-S2"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1152\/japplphysiol.00040.2009","article-title":"Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation","volume":"107","author":"Goodman","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"ref_57","first-page":"1360","article-title":"Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits","volume":"20","author":"Sevin","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1126\/science.3616607","article-title":"Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy","volume":"237","author":"Pion","year":"1987","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ito, T., Oishi, S., Takai, M., Kimura, Y., Uozumi, Y., Fujio, Y., Schaffer, S.W., and Azuma, J. (2010). Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice. J. Biomed. Sci., 17.","DOI":"10.1186\/1423-0127-17-S1-S20"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jjcc.2011.01.007","article-title":"Effect of taurine supplementation on exercise capacity of patients with heart failure","volume":"57","author":"Beyranvand","year":"2011","journal-title":"J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5114\/ceh.2022.119216","article-title":"Cellular and mitochondrial taurine depletion in bile duct ligated rats: A justification for taurine supplementation in cholestasis\/cirrhosis","volume":"8","author":"Najibi","year":"2022","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Liu, J., Ai, Y., Niu, X., Shang, F., Li, Z., Liu, H., Li, W., Ma, W., Chen, R., and Wei, T. (2020). Taurine protects against cardiac dysfunction induced by pressure overload through SIRT1-p53 activation. Chem. Biol. Interact., 317.","DOI":"10.1016\/j.cbi.2020.108972"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"102879","DOI":"10.1016\/j.psj.2023.102879","article-title":"Spermidine alleviating oxidative stress and apoptosis by inducing autophagy of granulosa cells in Sichuan white geese","volume":"102","author":"Jiang","year":"2023","journal-title":"Poult. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"765591","DOI":"10.3389\/fcvm.2021.765591","article-title":"Spermidine Affects Cardiac Function in Heart Failure Mice by Influencing the Gut Microbiota and Cardiac Galectin-3","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/cjp.cjp_76_21","article-title":"A study of the cardioprotective effect of spermidine: A novel inducer of autophagy","volume":"64","author":"Omar","year":"2021","journal-title":"Chin. J. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Martinelli, O., Peruzzi, M., Bartimoccia, S., D\u2019Amico, A., Marchitti, S., Rubattu, S., Chiariello, G.A., D\u2019ambrosio, L., Schiavon, S., and Miraldi, F. (2022). Natural Activators of Autophagy Increase Maximal Walking Distance and Reduce Oxidative Stress in Patients with Peripheral Artery Disease: A Pilot Study. Antioxidants, 11.","DOI":"10.3390\/antiox11091836"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: An open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_68","first-page":"305","article-title":"Galectin-3 as a multifunctional protein","volume":"9","author":"Krzeslak","year":"2004","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cyto.2011.06.001","article-title":"Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function","volume":"55","author":"Wanninger","year":"2011","journal-title":"Cytokine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1139\/cjpp-2015-0284","article-title":"Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells","volume":"94","author":"Elkashef","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_71","first-page":"599","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)","volume":"41","author":"Dong","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Al-Salam, S., Kandhan, K., Sudhadevi, M., Yasin, J., and Tariq, S. (2022). Early Doxorubicin Myocardial Injury: Inflammatory, Oxidative Stress, and Apoptotic Role of Galectin-3. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012479"},{"key":"ref_73","first-page":"10","article-title":"Controversies regarding albumin therapy in cirrhosis","volume":"7","author":"Trebicka","year":"2023","journal-title":"Hepatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e13107","DOI":"10.14814\/phy2.13107","article-title":"Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia-reperfusion","volume":"5","author":"Mapanga","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00018-023-04818-4","article-title":"Hydrogen therapy as a potential therapeutic intervention in heart disease: From the past evidence to future application","volume":"80","author":"Saengsin","year":"2023","journal-title":"Cell Mol. Life Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.52964\/AMJA.0179","article-title":"A case of orthodeoxia platypnoea in a patient with adult polycystic kidney and liver disease with a patent foramen ovale","volume":"6","author":"Graves","year":"2007","journal-title":"Acute Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.04.006","article-title":"Molecular hydrogen as a preventive and therapeutic medical gas: Initiation, development and potential of hydrogen medicine","volume":"144","author":"Ohta","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_78","first-page":"1048","article-title":"Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I\/R injury via PINK-mediated autophagy","volume":"44","author":"Yao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.hlc.2014.11.018","article-title":"Cardioprotective Effect of Hydrogen-rich Saline on Isoproterenol-induced Myocardial Infarction in Rats","volume":"24","author":"Jing","year":"2015","journal-title":"Heart Lung Circ."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/hepr.12379","article-title":"Concomitant inhibition of oxidative stress and angiogenesis by chronic hydrogen-rich saline and N-acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats","volume":"45","author":"Lee","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"598359","DOI":"10.3389\/fimmu.2020.598359","article-title":"Hydrogen in Patients with Corticosteroid-Refractory\/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial","volume":"11","author":"Qian","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jjcc.2023.04.007","article-title":"Cirrhotic cardiomyopathy: Predictors of major adverse cardiac events and assessment of reversibility after liver transplant","volume":"82","author":"Ali","year":"2023","journal-title":"J. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/lt.500060510","article-title":"Cirrhotic cardiomyopathy and liver transplantation","volume":"6","author":"Myers","year":"2000","journal-title":"Liver Transpl."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4240\/wjgs.v7.i6.86","article-title":"Intraoperative blood loss in orthotopic liver transplantation: The predictive factors","volume":"7","author":"Pandey","year":"2015","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4254\/wjh.v7.i3.507","article-title":"Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients","volume":"7","author":"Rahman","year":"2015","journal-title":"World J. Hepatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/5849\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:49:14Z","timestamp":1760107754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/5849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":85,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25115849"],"URL":"https:\/\/doi.org\/10.3390\/ijms25115849","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}